A Protocol for Simple, Rapid, and Direct Detection of SARS-CoV-2 from clinical samples, using Reverse Transcribed Loop-Mediated Isothermal Amplification (RT-LAMP).
Colorimetric
Covid-19
Isothermal
Pandemic
RT-LAMP
Rapid molecular Detection
SARS-CoV-2
Saliva.
Journal
Bio-protocol
ISSN: 2331-8325
Titre abrégé: Bio Protoc
Pays: United States
ID NLM: 101635102
Informations de publication
Date de publication:
20 Oct 2020
20 Oct 2020
Historique:
received:
14
06
2020
revised:
18
08
2020
accepted:
20
08
2020
entrez:
4
3
2021
pubmed:
5
3
2021
medline:
5
3
2021
Statut:
epublish
Résumé
SARS-CoV-2 has quickly spread all around the globe causing illness and wide damages. Most countries were unprepared for such a rapid spread and crisis. This led to various strategies for effective control of the new pandemic. A key aspect in all countries was to effectively test the population for the virus. Most countries chose a lockdown strategy in which many workplaces and activities are completely closed, leading to substantial economy costs. Here, we present a protocol we recently developed that allows rapid and simple detection of SARS-CoV-2 for the large population, eliminating costs and involvement of professional teams and laboratories. This protocol is based on Reverse Transcribed Loop-Mediated Isothermal Amplification (RT-LAMP). We tested this protocol directly on patient samples, both nasal and throat clinical swabs as well as saliva. Notably, this protocol is simple, cheap and can be easily applied to other pathogens as well.
Identifiants
pubmed: 33659444
doi: 10.21769/BioProtoc.3789
pii: e3789
pmc: PMC7842347
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e3789Informations de copyright
Copyright © 2020 The Authors; exclusive licensee Bio-protocol LLC.
Déclaration de conflit d'intérêts
Competing interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. While performing this research, no company had invested in the research, and no commercialization was intended.
Références
Nucleic Acids Res. 2000 Jun 15;28(12):E63
pubmed: 10871386
Exp Biol Med (Maywood). 2020 Aug;245(14):1187-1193
pubmed: 32668983
J Virol Methods. 2016 Dec;238:86-93
pubmed: 27793644
PLoS Biol. 2020 Oct 2;18(10):e3000896
pubmed: 33006983
Clin Chem. 2020 Jul 1;66(7):975-977
pubmed: 32315390
J Virol Methods. 2018 May;255:91-97
pubmed: 29474813